pharmaceutical daily

Lynparza – API Insight, 2019-2021: Historical & Forecasted Sales Revenues – ResearchAndMarkets.com

Illustration

DUBLIN–(BUSINESS WIRE)–The “Lynparza
– API Insight, 2019”
drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Lynparza – API Insight, 2019 provides product and API
manufacturers’ details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Lynparza. The report also highlights the patent
details of Lynparza.

Scope of the Report

Reasons to Buy

Key Topics Covered

1. Lynparza Overview

2. Lynparza Global Sales Assessment

3. Product Description

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/c7b2z3

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Ovarian
Cancer Drugs

Exit mobile version